• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

    2/14/25 8:30:09 AM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $STRR alert in real time by email

    OLD GREENWICH, Conn., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star Equity" or the "Company"), a diversified holding company, announced today that its Board of Directors (the "Board") declared a cash dividend to holders of the Company's 10% Series A Cumulative Perpetual Preferred Stock of $0.25 per share. The record date for this dividend is March 1, 2025, and the payment date is March 10, 2025.

    About Star Equity Holdings, Inc.

    Star Equity Holdings, Inc. is a diversified holding company currently with two divisions: Building Solutions and Investments.

    Building Solutions

    Our Building Solutions division operates in three businesses: (i) modular building manufacturing; (ii) structural wall panel and wood foundation manufacturing, including building supply distribution operations; and (iii) glue-laminated timber ("glulam") column, beam, and truss manufacturing.

    Investments

    Our Investments division manages and finances the Company's real estate assets as well as its investment positions in private and public companies.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this press release that are not statements of historical fact are hereby identified as "forward-looking statements" for the purpose of the safe harbor provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are based upon management's current beliefs, views, estimates and expectations, including as pertains to (i) the plans and objectives of management for future operations, including plans or objectives relating to acquisitions and related integration, (ii) projections of income, EBITDA, earnings per share, capital expenditures, cost reductions, capital structure or other financial items, (iii) the future financial performance of the Company or acquisition targets and (iv) the assumptions underlying or relating to any statement described above. Forward-looking statements generally are identified by the words "believe", "expect", "anticipate", "estimate", "project", "intend", "plan", "should", "may", "will", "would", "will be", "will continue" or similar expressions. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described above as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the cyclical nature of our operating businesses, the Company's debt and its ability to repay, refinance, or incur additional debt in the future; the Company's need for a significant amount of cash to service, repay the debt, and to pay dividends on the Company's preferred stock; the restrictions contained in the debt agreements that limit the discretion of management in operating the business; legal, regulatory, political and economic risks in markets and public health crises that reduce economic activity and cause restrictions on operations; the length of time associated with servicing customers; losses of significant contracts or failure to get potential contracts being discussed; disruptions in the relationship with third party vendors; accounts receivable turnover; insufficient cash flows and resulting lack of liquidity; the Company's inability to expand its business operations; the liability and compliance costs regarding environmental regulations; the lack of product diversification; existing or increased competition; risks to the price and volatility of the Company's common stock and preferred stock; stock volatility and in liquidity; risks to preferred stockholders of not receiving dividends and risks to the Company's ability to pursue growth opportunities if the Company continues to pay dividends according to the terms of the Company's preferred stock; the Company's ability to execute on its business strategy (including any cost reduction plans); the Company's failure to realize expected benefits of restructuring and cost-cutting actions; the Company's ability to preserve and monetize its net operating losses; risks associated with the Company's possible pursuit of acquisitions; the Company's ability to consummate successful acquisitions and execute related integration; general economic and financial market conditions; failure to keep pace with evolving technologies and difficulties integrating technologies; system failures; losses of key management personnel and the inability to attract and retain highly qualified management and personnel in the future; and the continued demand for and market acceptance of the Company's services. For a detailed discussion of cautionary statements and risks that may affect the Company's future results of operations and financial results, please refer to the Company's filings with the Securities and Exchange Commission, including, but not limited to, the risk factors in the Company's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. This press release reflects management's views as of the date presented.

    All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations. Therefore, you are cautioned not to place undue reliance on such statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.

    For more information contact: 
    Star Equity Holdings, Inc.The Equity Group
    Richard K. Coleman Jr.Lena Cati
    Chief Executive OfficerSenior Vice President
    203-489-9501212-836-9611
    [email protected][email protected]


    Primary Logo

    Get the next $STRR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $STRR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $STRR
    SEC Filings

    See more
    • SEC Form 425 filed by Star Equity Holdings Inc.

      425 - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      5/21/25 9:44:38 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

      5/21/25 9:40:28 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

      5/20/25 4:09:26 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Star Equity Holdings Inc.

      SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      9/10/24 4:04:39 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D/A filed by Star Equity Holdings Inc. (Amendment)

      SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      9/18/23 4:05:02 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D/A filed by Star Equity Holdings Inc. (Amendment)

      SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      8/31/23 5:18:25 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Parks Louis A.

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      5/21/25 4:14:38 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Executive Chairman Eberwein Jeffrey E.

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      5/21/25 4:13:02 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Director Palmer Jennifer

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      5/21/25 4:11:19 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Financials

    Live finance-specific insights

    See more

    $STRR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Star Equity Holdings and Hudson Global Sign Definitive Merger Agreement

      Accretive Combination Increases Scale, Diversifies Revenue Streams, and Leverages Corporate Overhead and Public Company Costs Better Positions both Companies to Accelerate Growth and Maximize Shareholder Value Companies to Host a Joint Conference Call on May 22 at 10:00 am ET to Discuss the Merger OLD GREENWICH, Conn., May 21, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. ("Star") (NASDAQ:STRR, STRRP)) and Hudson Global, Inc. ("Hudson") (NASDAQ:HSON) (the "Companies"), announced today the signing of a definitive merger agreement (the "Merger"). Pursuant to the Merger, Star will merge with and into a wholly owned subsidiary of Hudson to form "NewCo". Prior to signing this Merger a

      5/21/25 4:45:03 PM ET
      $HSON
      $STRR
      Professional Services
      Consumer Discretionary
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

      OLD GREENWICH, Conn., May 20, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, announced today that its Board of Directors declared a cash dividend to holders of the Company's 10% Series A Cumulative Perpetual Preferred Stock of $0.25 per share. The record date for this dividend is June 1, 2025, and the payment date is June 10, 2025. About Star Equity Holdings, Inc.Star Equity Holdings, Inc. is a diversified holding company currently composed of three business divisions: Building Solutions, Energy Services, and Investments. Building SolutionsOur Building Solutions division operates in three businesses: (i)

      5/20/25 8:30:43 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Announces 2025 First Quarter Financial Results

      Q1 2025 revenues increased to $12.9 million vs. $9.1 million in Q1 2024 Alliance Drilling Tools acquisition marks entry into Energy Services Quarter-end Building Solutions backlog stands at record $27.9 million OLD GREENWICH, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, reported today its financial results for the first quarter (Q1) ended March 31, 2025. All 2025 and 2024 amounts in this release are unaudited. Q1 2025 Financial Highlights vs. Q1 2024 (unaudited) Revenues increased by 41.7% to $12.9 million from $9.1 million.Gross profi

      5/14/25 8:30:04 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings and Hudson Global Sign Definitive Merger Agreement

      Accretive Combination Increases Scale, Diversifies Revenue Streams, and Leverages Corporate Overhead and Public Company Costs Better Positions both Companies to Accelerate Growth and Maximize Shareholder Value Companies to Host a Joint Conference Call on May 22 at 10:00 am ET to Discuss the Merger OLD GREENWICH, Conn., May 21, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. ("Star") (NASDAQ:STRR, STRRP)) and Hudson Global, Inc. ("Hudson") (NASDAQ:HSON) (the "Companies"), announced today the signing of a definitive merger agreement (the "Merger"). Pursuant to the Merger, Star will merge with and into a wholly owned subsidiary of Hudson to form "NewCo". Prior to signing this Merger a

      5/21/25 4:45:03 PM ET
      $HSON
      $STRR
      Professional Services
      Consumer Discretionary
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

      OLD GREENWICH, Conn., May 20, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, announced today that its Board of Directors declared a cash dividend to holders of the Company's 10% Series A Cumulative Perpetual Preferred Stock of $0.25 per share. The record date for this dividend is June 1, 2025, and the payment date is June 10, 2025. About Star Equity Holdings, Inc.Star Equity Holdings, Inc. is a diversified holding company currently composed of three business divisions: Building Solutions, Energy Services, and Investments. Building SolutionsOur Building Solutions division operates in three businesses: (i)

      5/20/25 8:30:43 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Announces 2025 First Quarter Financial Results

      Q1 2025 revenues increased to $12.9 million vs. $9.1 million in Q1 2024 Alliance Drilling Tools acquisition marks entry into Energy Services Quarter-end Building Solutions backlog stands at record $27.9 million OLD GREENWICH, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, reported today its financial results for the first quarter (Q1) ended March 31, 2025. All 2025 and 2024 amounts in this release are unaudited. Q1 2025 Financial Highlights vs. Q1 2024 (unaudited) Revenues increased by 41.7% to $12.9 million from $9.1 million.Gross profi

      5/14/25 8:30:04 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Leadership Updates

    Live Leadership Updates

    See more
    • Star Equity Holdings, Inc. Appoints Rick Coleman as CEO

      OLD GREENWICH, Conn., April 01, 2022 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified holding company, announced today the appointment of Richard ("Rick") K. Coleman, Jr. as Chief Executive Officer, effective April 1, 2022. In addition, Mr. Coleman will be nominated to serve as a director at the Company's upcoming annual meeting of shareholders. Mr. Coleman is a seasoned executive who brings to Star Equity extensive CEO leadership and board-level experience with numerous public and private companies. He was appointed as Star Equity's Chief Operating Officer in January 2022 and has provided valuable insights and direction

      4/1/22 8:00:00 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Adds Richard Coleman as Chief Operating Officer

      OLD GREENWICH, Conn., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified holding company, announced today the appointment of Richard K. Coleman, Jr. ("Rick") as Chief Operating Officer, effective January 1, 2022. Coleman's addition increases the capacity of Star Equity's senior leadership team. In this role, he will oversee the Company's operations, assist its business leaders in achieving their growth and profitability goals, launch new business initiatives, as well as help analyze and integrate future acquisitions. Coleman brings more than 30 years of executive leadership experience with extensive expertis

      12/20/21 8:00:00 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Appoints John Gildea to its Board of Directors

      OLD GREENWICH, Conn., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified, multi-industry holding company with three business divisions, Healthcare, Construction, and Investments, announced today the appointment of John W. Gildea to its Board of Directors, effective immediately. Mr. Gildea's appointment as independent director expands Star Equity's Board to six members. Mr. Gildea will also serve on the Audit Committee. Mr. Gildea brings over three decades of experience investing in special situation debt and equity of small to middle market companies. He is the founding partner of Gildea Management Co., a fir

      8/6/21 4:38:13 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Coleman Richard Kenneth Jr. bought $10,675 worth of shares (2,500 units at $4.27) and bought $4,925 worth of 10% Series A Cumulative Perpetual Preferred Stock (500 units at $9.85), decreasing direct ownership by 93% to 2,500 units (SEC Form 4)

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      8/20/24 4:10:35 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Butcher Thatcher bought $3,120 worth of shares (3,000 units at $1.04), increasing direct ownership by 100% to 6,000 units (SEC Form 4)

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      12/15/23 1:41:36 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Coleman Richard Kenneth Jr. bought $2,220 worth of shares (2,000 units at $1.11) and bought $18,900 worth of 10% Series A Cumulative Perpetual Preferred Stock (2,000 units at $9.45), decreasing direct ownership by 98% to 2,000 units (SEC Form 4)

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      12/4/23 8:25:38 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care